Literature DB >> 19559432

Diagnostic and therapeutic procedure with a short double-balloon enteroscope and cholangioscopy in a patient with acute cholangitis due to hepatolithiasis.

Makoto Takaoka1, Masaaki Shimatani, Tsukasa Ikeura, Masanori Koyabu, Takeo Kusuda, Norimasa Fukata, Mitsunobu Matsushita, Kazuichi Okazaki.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19559432     DOI: 10.1016/j.gie.2009.04.018

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


× No keyword cloud information.
  5 in total

Review 1.  Current status of peroral cholangioscopy in biliary tract diseases.

Authors:  Stefania Ghersi; Lorenzo Fuccio; Marco Bassi; Carlo Fabbri; Vincenzo Cennamo
Journal:  World J Gastrointest Endosc       Date:  2015-05-16

2.  Effectiveness of peroral direct cholangioscopy using an ultraslim endoscope for the treatment of hepatolithiasis in patients with hepaticojejunostomy (with video).

Authors:  Kazuyuki Matsumoto; Koichiro Tsutsumi; Hironari Kato; Yutaka Akimoto; Daisuke Uchida; Takeshi Tomoda; Naoki Yamamoto; Yasuhiro Noma; Shigeru Horiguchi; Hiroyuki Okada; Kazuhide Yamamoto
Journal:  Surg Endosc       Date:  2015-06-27       Impact factor: 4.584

Review 3.  Recent developments in choledochoscopy: technical and clinical advances.

Authors:  Ming-Ming Xu; Michel Kahaleh
Journal:  Clin Exp Gastroenterol       Date:  2016-05-11

Review 4.  Step-by-step strategy in the management of residual hepatolithiasis using post-operative cholangioscopy.

Authors:  Xu-Dong Wen; Tao Wang; Zhu Huang; Hong-Jian Zhang; Bing-Yin Zhang; Li-Jun Tang; Wei-Hui Liu
Journal:  Therap Adv Gastroenterol       Date:  2017-09-21       Impact factor: 4.409

5.  Large Gallstones Stacked Together in the Common Bile Duct after Choledochojejunostomy.

Authors:  Yuri Sakamoto; Yohei Takeda; Shiho Kawahara; Takuya Shimosaka; Wataru Hamamoto; Hiroki Koda; Taro Yamashita; Takumi Onoyama; Kazuya Matsumoto; Hajime Isomoto
Journal:  Intern Med       Date:  2022-02-19       Impact factor: 1.282

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.